TY - JOUR
AU - Lindley Richard
AU - Sandercock P.
AU - Cohen G.
AU - Murray G.
AU - Wardlaw J.
AU - Whiteley W.
AU - Thompson D.
AD - From the Divisions of Clinical Neurosciences (W.N.W., G.C., P.S.) and Neuroimaging Sciences (J.W.), University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom; Edinburgh MRC Hub for Trials Methodology Research, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom (D.T., G.M.); and Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney, Sydney, Australia (R.I.L.).
AN - 24603072
BT - Stroke
DP - NLM
ET - 2014/03/08
LA - Eng
M1 - 4
N1 - Whiteley, William N<br/>Thompson, Douglas<br/>Murray, Gordon<br/>Cohen, Geoff<br/>Lindley, Richard I<br/>Wardlaw, Joanna<br/>Sandercock, Peter<br/>on behalf of the IST-3 Collaborative Group<br/>Stroke. 2014 Mar 6.
PY - 2014
SN - 1524-4628 (Electronic) - 0039-2499 (Linking)
SP - 1000
EP - 6
T2 - Stroke
TI - Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial
VL - 45
ER -